Riskpilot← Back to searchSign inGet full accessPRECISE INGREDIENTS ApS
APSActiveCVR 27757103Tinglykke 10Manufacture of basic pharmaceutical products · NACE 2110Est. 20041 employees
Revenue 2024
DKK 545K
-9% vs 2023
EBITDA margin
100.0%
-9% vs 2023
Equity ratio
65.0%
Financial strength
Net profit 2024
DKK 582K
+55% vs 2023
| Revenue | DKK 545K | -9% |
| EBITDA | DKK 545K | -9% |
| Net profit | DKK 582K | +55% |
| Total assets | DKK 1,1M | -46% |
| Equity | DKK 714K | -25% |
| Employees | 1 | — |
Legal name
PRECISE INGREDIENTS ApS
CVR number
27757103
Legal form
Anpartsselskab
NACE code
2110 · Manufacture of basic pharmaceutical products
Founded
24. maj 2004
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen i forening med en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er handel, herunder eksport, import og produktion samt anden i forbindelse hermed stående virksomhed.
Address
Tinglykke 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -13 | 40 | 107 | 194 | 566 | 780 | 447 | 659 | 330 | 196 | 196 | 597 | 545 |
| Staff expenses | -0 | -0 | -0 | -0 | -316 | -350 | -320 | -354 | -231 | -43 | -0 | -0 | -0 |
| EBITDA | -13 | 40 | 107 | 194 | 250 | 430 | 127 | 305 | 99 | 153 | 196 | 597 | 545 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -15 | -13 | -31 | -13 | -1 | -0 | -0 | -0 |
| EBIT | -13 | 40 | 107 | 194 | 250 | 415 | 113 | 274 | 86 | 152 | 196 | 597 | 545 |
| Net financials | 0 | -3 | 54 | -39 | -32 | -232 | 68 | -43 | 127 | 80 | 148 | -114 | 201 |
| Profit before tax | -13 | 37 | 161 | 155 | 218 | 183 | 182 | 232 | 213 | 232 | 344 | 483 | 747 |
| Tax | -0 | -0 | 35 | 36 | 47 | 40 | 40 | 51 | 47 | 51 | 76 | 106 | 164 |
| Net profit | -13 | 37 | 126 | 119 | 171 | 143 | 142 | 181 | 166 | 181 | 268 | 377 | 582 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 37 | 1.149 | 1.292 | 778 | 2.900 | 3.497 | 3.919 | 1.748 | 5.733 | 1.648 | 900 | 2.048 | 1.100 |
| Equity | 32 | 69 | 195 | 315 | 335 | 278 | 270 | 450 | 297 | 307 | 576 | 952 | 714 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 5 | 1.080 | 1.096 | 463 | 2.565 | 3.219 | 3.650 | 1.298 | 5.436 | 1.341 | 325 | 1.096 | 386 |
| Total debt | 5 | 1.080 | 1.096 | 463 | 2.565 | 3.219 | 3.650 | 1.298 | 5.436 | 1.341 | 325 | 1.096 | 386 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20122024
Return on equity
81.5%
This company
18.4%
Market median
+343% vs market
20122024
Net profit margin
106.8%
This company
8.1%
Market median
+1219% vs market
20122024
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20122024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EW Management | Management | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMA NORD ApS | Company | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMCO I ApS
PRECISE INGREDIENTS ApS Board members of PRECISE INGREDIENTS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eli Wallin | Management | 0 companies |
| Jørgen Dam | Board of Directors | 0 companies |
| Sven Moesgaard | Board of Directors | 0 companies |